23 Feb 2010:
Correction: Mycolactone Gene Expression Is Controlled by Strong SigA-Like Promoters with Utility in Studies of
Mycolactone A/B is a lipophilic macrocyclic polyketide that is the primary virulence factor produced by Mycobacterium ulcerans, a human pathogen and the causative agent of Buruli ulcer. In M. ulcerans strain Agy99 the mycolactone polyketide synthase (PKS) locus spans a 120 kb region of a 174 kb megaplasmid. Here we have identified promoter regions of this PKS locus using GFP reporter assays, in silico analysis, primer extension, and site-directed mutagenesis. Transcription of the large PKS genes mlsA1 (51 kb), mlsA2 (7 kb) and mlsB (42 kb) is driven by a novel and powerful SigA-like promoter sequence situated 533 bp upstream of both the mlsA1 and mlsB initiation codons, which is also functional in Escherichia coli, Mycobacterium smegmatis and Mycobacterium marinum. Promoter regions were also identified upstream of the putative mycolactone accessory genes mup045 and mup053. We transformed M. ulcerans with a GFP-reporter plasmid under the control of the mls promoter to produce a highly green-fluorescent bacterium. The strain remained virulent, producing both GFP and mycolactone and causing ulcerative disease in mice. Mosquitoes have been proposed as a potential vector of M. ulcerans so we utilized M. ulcerans-GFP in microcosm feeding experiments with captured mosquito larvae. M. ulcerans-GFP accumulated within the mouth and midgut of the insect over four instars, whereas the closely related, non-mycolactone-producing species M. marinum harbouring the same GFP reporter system did not. This is the first report to identify M. ulcerans toxin gene promoters, and we have used our findings to develop M. ulcerans-GFP, a strain in which fluorescence and toxin gene expression are linked, thus providing a tool for studying Buruli ulcer pathogenesis and potential transmission to humans.
Buruli ulcer (BU) is a serious skin infection of humans predominantly occurring in West and Central Africa. The disease is caused by infection with Mycobacterium ulcerans, a bacterium that produces an unusual toxin called mycolactone. There are many unanswered questions surrounding BU, particularly regarding the role of mycolactone in disease and how M. ulcerans is transmitted to humans. Here, we have partly addressed these questions by identifying genetic factors controlling the transcription of the mycolactone genes. Using a variety of experimental approaches, including green fluorescent protein (GFP) as a reporter of gene expression, we have identified strong promoters that drive transcription of the mycolactone genes in M. ulcerans. We then used our GFP reporters to produce highly fluorescent M. ulcerans-GFP that were readily visualized by microscopy. Mosquitoes have been proposed as a potential vector of M. ulcerans so we used M. ulcerans-GFP in feeding experiments with mosquito larvae. M. ulcerans-GFP accumulated within the insects, whereas other mycobacteria did not. This is the first report of the mycolactone gene promoters, and we have used our findings to develop M. ulcerans-GFP, a strain in which fluorescence and toxin gene expression are linked, thus providing a powerful tool for studying Buruli ulcer.
Citation: Tobias NJ, Seemann T, Pidot SJ, Porter JL, Marsollier L, Marion E, et al. (2009) Mycolactone Gene Expression Is Controlled by Strong SigA-Like Promoters with Utility in Studies of Mycobacterium ulcerans and Buruli Ulcer. PLoS Negl Trop Dis 3(11): e553. doi:10.1371/journal.pntd.0000553
Editor: Mathieu Picardeau, Institut Pasteur, France
Received: August 10, 2009; Accepted: October 19, 2009; Published: November 24, 2009
Copyright: © 2009 Tobias et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This research was supported in part by the National Health and Medical Research Council of Australia. This research was also supported by the Fondation Française Raoul Follereau, the Institut National de la Santé et de la Recherche Médicale (INSERM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Mycobacterium ulcerans is the causative agent of Buruli ulcer (BU) an emerging but neglected disease found predominantly in tropical regions of the world and with an increasing incidence in West and Central Africa ,. BU is a chronic infection of subcutaneous tissue that can result in high morbidity such as permanent scarring and functional disabilities. The combination of rifampin and an aminoglycoside for four to eight weeks leads to the healing of early lesions without radical surgery and is now the recommended standard regimen . However, substantial tissue damage often necessitates surgery . The social and economic burden of BU can be severe, particularly in impoverished rural regions of West Africa where the prevalence of BU is sometimes higher than that of the two most significant mycobacterial diseases, leprosy and tuberculosis. Cases of BU are usually clustered around swamps and slow-flowing water and while the mode of transmission of M. ulcerans is unknown, evidence to date suggests, fish , snails  and certain carnivorous aquatic insects , can all harbour the bacterium. Recent studies in Australia suggest mosquitoes may play a role in transmission ,.
A major factor influencing the pathology of Buruli ulcer is the production by M. ulcerans of a secondary metabolite called mycolactone . Mycolactone is an immunosuppressive and cytotoxic macrocyclic polyketide, characterised by a 12-membered macrolactone core appended to a highly unsaturated acyl side chain ,. Polyketides are a class of naturally occurring compounds, some of which have potent pharmaceutical activity such as the immune suppressor rapamycin, the antibiotic erythromycin A, and the antiparasitic agent avermectin –. Why M. ulcerans produces mycolactone is unknown. However, studies on the effect of the molecule in cell culture and animal models have shown that in the microgram range it has cytotoxic properties, while at sub-cytotoxic concentrations it has immunomodulatory properties, most strikingly the inhibition of tumour necrosis factor production by monocytes and macrophages –. In mice, mycolactone has been shown to concentrate within peripheral blood monocytes .
Mycolactone synthesis is dependent on the pMUM megaplasmid found in M. ulcerans and closely related mycobacteria (Figure 1) –. This plasmid contains three, very large genes (mlsA1: 51 kb, mlsA2: 7 kb, and mlsB: 42 kb) that encode type I polyketide synthases (PKS). MlsA1 and MlsA2 synthesize the upper side chain and macrolactone core, whilst MlsB synthesizes the acyl side chain . A putative beta-ketoacyl transferase encoded by another pMUM gene, mup045, is thought to catalyse the ester linkage between the acyl side chain and the macrolactone core whilst a P450 hydroxylase, encoded by mup053, oxidizes the side chain at C12′ (Figure 1) –. A third gene, mup038, is predicted to encode a type II thioesterase that might be required for removing aberrant polyketide extension products from the Mls PKS that form during synthesis. An unusual feature of the mycolactone PKS is the very high level of sequence identity between domains of the same function (98.7–100% nt identity and 98.3–100% aa identity). This observation suggested that the evolution of the locus may be recent and also prone to rearrangements that result in either loss of mycolactone production or production of new mycolactones. These hypotheses have recently gained support by studies that have shown (i) all mycolactone producing mycobacteria (which includes M. ulcerans and some closely related fish and frog pathogens) have recently evolved from a common Mycobacterium marinum ancestor by pMUM plasmid acquisition –, (ii) laboratory passaging leads to mycolactone negative mutants through spontaneous deletion of mls gene fragments , and (iii) natural swapping of particular acyltransferase and ketoreductase domains and loss or gain of entire extension modules in some strains of M. ulcerans has led to the production of new mycolactones ,.
The regions upstream of key genes involved in mycolactone biosynthesis cloned into pSM20 and the names of the resulting plasmid GFP-reporter constructs are indicated. The 8.4 kb duplicated region that spans the load modules of mlsA1 and mlsB and 1.6 kb upstream of each gene is circled. E = EcoRV, B = BamHI, S = SphI, ‘*’ indicates that this single construct represents the encircled duplicated regions upstream of mlsA1 and mlsB.
However, there have been very few studies of gene expression in M. ulcerans. Therefore, in this study we began by investigation of the mycolactone-associated genes mlsA1/mlsA2, mlsB, mup045, mup053 and mup038. Promoter regions were mapped upstream of the above genes using a GFP reporter. Putative transcriptional start sites and promoter sequences were then identified by primer extension analysis and site-directed mutagenesis. The GFP reporter containing the promoter region of the mls genes was then used to transform M. ulcerans. This recombinant GFP M. ulcerans fluoresced brightly and was used to follow infection in both mice and mosquito larvae.
Materials and Methods
Bacterial strains and culture conditions
The bacterial strains and plasmids used in this study are described in Table S1. All cloning experiments were performed in Escherichia coli DH10B, cultivated in Luria-Bertani (LB) broth at 37°C or on LB agar containing 50 µg kanamycin, for 16 hours at 37°C. Mycobacterial strains were grown in Middlebrook 7H9 medium (Difco) supplemented with albumin (6.25% (w/v)), dextrose (2.5% (w/v)), sodium chloride (1.1% (w/v)), catalase (5×10−4% (w/v)) and 0.05% (v/v) Tween−80 at 37°C for Mycobacterium smegmatis and 30°C for M. marinum and M. ulcerans. Mycobacteria were also cultured on 7H10 agar supplemented with OADC (Difco). Recombinant mycobacteria were cultivated with kanamycin at a final concentration of 25 µg ml−1.
Standard methods were used for cloning, PCR and DNA sequencing. The oligonucleotides used in this study for PCR, RT-PCR and DNA sequencing are listed in Table S2. Genomic DNA was extracted from mycobacteria as described . The broad host range, promoterless, GFP (gfpmut3) vector pSM20, that replicates in E. coli, Corynebacterium sp. and Mycobacterium sp, was used for all promoter cloning experiments . PCR products derived from the upstream regions were modified using oligonucleotides described in Table S2 and ligated into the unique restriction enzyme sites immediately upstream of the gfp gene in pSM20 (Figure 1). Constructs were confirmed to be correct by DNA sequencing and then transformed into M. smegmatis mc2155 as described . Electrocompetent M. marinum and M. ulcerans were prepared as described  and these cells were transformed with 10 µg of DNA from plasmid pJKD2893 (Table S1). The constructs were confirmed to be correct in mycobacteria by Southern hybridization and back transformation to E. coli. Acetone soluble lipids were extracted from recombinant M. ulcerans and analysed by LC-MS for the presence of mycolactones as previously described .
Measurement of green fluorescence protein (GFP) expression
GFP expression in pSM20 and derivatives (Table S1) was measured using a FLUOstar OPTIMA plate scanner (BMG Lab Technologies). M. smegmatis strains were grown to an OD of 1.0 using a WPA CO8000 cell density meter (Isogen Life Science). For each strain, 30 µl of starter culture was added to each of 16 wells of a 96-well flat-bottomed clear plate containing 150 µl of fresh 7H9 medium. Plates were incubated at 37°C for 30 mins. Each well was scanned using an excitation filter of 485 nm and an emission filter of 520 nm. Fluorescence readings were taken every 10 minutes and the average of 20 flashes per well was taken to be the measure of fluorescence. Prior to each reading, the plates were shaken for 5 minutes in an orbital motion. Replicates were averaged for each experiment and the average value for the vector-only control was taken as background and subtracted from the average at each time point.
Preparation of total RNA
Total RNA was prepared from E. coli using the RNeasy mini kit as described and per the manufacturer's instructions (Qiagen) . For M. ulcerans, a 0.5 volume of RNAlater (Qiagen) was added to 100 ml of late log-phase culture and allowed to stand at room temperature for 10 minutes prior to centrifugation at 4,600 g, for 10 minutes. The resultant cell pellet was washed in 1 ml of 0.5% (v/v) Tween-80 per 50 mg of cells (wet weight), resuspended in 800 µl of RNA lysis buffer (0.12 M sodium acetate (pH 4.0), 9.6% (v/v) liquid Pyroneg (Diversey), pH 4.0) and then added to 250 µg of glass beads (Sigma Aldrich), with 600 µl of acidified phenol:chloroform (pH 4.0) (Sigma Aldrich). Cells were disrupted with a FastPrep tissue homogenizer (Savant Instruments) for 45 seconds, at speed 6 and chilled on ice for 5 minutes. The aqueous phase was then re-extracted with chloroform:isoamylalcohol (24:1) and precipitated with isopropanol, and 3 M sodium acetate (pH 4.6). Two 70% (v/v) ethanol washes were performed and the pellet was dried briefly under vacuum and resuspended in 100 µl of DEPC water. RNA in this preparation was then further purified using an RNeasy extraction kit, including an on-column DNase treatment, following the manufacturers recommendations (Qiagen). For RNA extraction from M. smegmatis and M. marinum the following modifications to the above method were used. The cell pellet was first resuspended in 2 ml of lysis solution (20 mM potassium acetate (pH 4.8), 1 mM EDTA, 0.5% (v/v) SDS, 100 µg proteinase K ml−1). One millilitre was added to 250 µg of glass beads with 700 µl acidified phenol:chloroform pH 4.0. Cells were disrupted by three cycles in a FastPrep instrument at speed 5, for 30 seconds, and then centrifuged at 17,900 g for 10 minutes. The aqueous phase was recovered and extracted once with 500 µl phenol:chloroform (pH 4.0) followed by a chloroform only extraction. Nucleic acids were precipitated as above and RNA extraction proceeded as for M. ulcerans using the RNeasy extraction kit.
The primer extension protocol used was modified from Lloyd et al., . Two reverse transcription reactions were performed. To the RNA-primer mix, 6 µl of 5x first strand buffer (Invitrogen), 15 mM DTT (Invitrogen), 1 mM dNTPs (Promega), 1 U RNasin (Promega) and 100 U of Superscript II RNase H- reverse transcriptase (Invitrogen) were added. After one hour at 42°C, 2 µl of 5x first strand buffer, 1.5 mM dNTPs, 1 U RNasin, 15 mM DTT and 100 U of Superscript II was added and incubated for a further hour at 42°C. Ten nanograms of RNaseA (Sigma) was then added and allowed to incubate at 37°C for 30 minutes. The resultant cDNA was precipitated and washed once with 70% (v/v) ethanol, dried and stored at −20°C until analysis. Capillary electrophoresis was performed on an Applied Biosystems 3730 DNA analyzer using Liz™ 500 size standards to generate a standard curve (Applied Biosystems). Genemapper® version 3.7 (Applied Biosystems) was used to analyze the sample files with automated allele calling verified by manual inspection. The sized cDNA fragments were then mapped to their respective first strand synthesis primer binding sites to identify the putative transcription start site.
From the alignment of each of the SigA, C, D, E, F, H & L promoters , nucleotide frequency counts were derived and used to construct a library of 110 position specific scoring matrices (PSSMs) for each sigma factor (PSSMs available upon request). This allowed the gap between the -35 and -10 signals to vary between 14 and 23 residues, and the gap between the -10 signal and the TSP to vary between 3 and 13 residues. PoSSuM software  was used to scan the pMUM001 genome for high scoring hits to these PSSM libraries , using a background model consistent with the G+C biased nucleotide distribution of pMUM001. A p-value significance cutoff of 0.0001 was used.
Splice overlap extension PCR  was used to alter the sequence of putative promoter motifs with oligonucleotides 1075-F and 1074-R for mlsA1/mlsB, 1667-F and 1668-R for mup045, and 1669-F and 1670-R for mup053 (Table S2). Each PCR reaction consisted of 20 cycles of 94°C for 1 minute, 50°C for 1 minute and 72°C for 3 minutes then 94°C for 1 minute, 72°C for 10 minutes and held at 4°C. Two overlapping PCR products were obtained and 2 µl (~50 ng DNA) of each were used in a subsequent reaction using the outermost primers for each product to yield a complete fragment incorporating both products. Each product was then ligated into pSM20 as described above. Mutations were confirmed by DNA sequencing.
Ten, six-week-old female BALB/c mice (Charles River France, http://www.criver.com/) were injected subcutaneously into the tail with 30 µl of a suspension containing 5×104 bacteria. To favour the growth of the GFP-expressing bacilli, animals received 0.1 ml of a solution containing 80 mg/ml of kanamycin (1% w/v), administered by oral gavage every day. The mice were killed and their tails were collected fifty days after inoculation.
Mice were maintained in the animal house facility of the Centre Hospitalier Universitaire, Angers, France (Animal Ethics Committee, Centre Hospitalier Universitaire, Agreement A 49 007 002), adhering to the institution's guidelines for animal husbandry.
Detection of cultivable bacilli and histology
The tissue specimens from mice were minced with disposable scalpels in a Petri dish and ground with a Potter–Elvehjem homogeniser, size 22, (Kimble/Kontes, Vineland, NJ), in 0.15 M NaCl to obtain a tenfold dilution. The suspension was decontaminated to remove other bacteria using an equal volume of N-acetyl-L-cysteine sodium hydroxide (2%)  and inoculated on 7H10 agar supplemented with OADC (Difco), containing 25 µg/ml of kanamycin. For histological examination, tissues were fixed in 4% paraformaldehyde in phosphate buffer (pH 7.4). Decalcification of the tissue was performed for 7 days in 0.1 M of EDTA solution in PBS. Samples were frozen in isopentane cooled to −140°C in liquid nitrogen and stored at −80°C for subsequent histochemical analysis. Eight-micron thick transverse sections were cut at −30°C on a cryostat (Jung-Reichert Cryocut 1800, Cambridge Instruments, Germany) and kept at −80°C until histochemical processing, which was done within 1 week of sectioning. For detection of GFP-expressing bacilli, tissues were counterstained with DAPI, with endogenous phosphatase activity first detected using alkaline phosphatase substrate kit I (Vector Laboratories). The preparation was then mounted in Vectashield mounting medium containing DAPI (Vector Laboratories) and the samples were visualized using fluorescence microscopy (Leica DM5000B). Hematoxylin phloxine saffron and Ziehl Nielsen staining were performed according to standard procedures.
Mosquito microcosm M. ulcerans-GFP feeding experiments
Mosquito larvae (Aedes camptorhynchus) between first and second instar were distributed into 4×50 ml plastic tubes (10 larvae per tube), containing 20 ml of sterile tap water. To three groups of four tubes were added 1.5 ml of an aqueous slurry of possum faecal material containing either 5×106 colony forming units (cfu) M. ulcerans-GFP, 5×106 cfu M. marinum-GFP, or possum faecal material alone. The larvae were left to feed on the material for one week at 24°C. At the end of one week and also at the end of every subsequent week up to week five, all larvae were transferred to new tubes containing 20 ml of sterilized tap water. The original tubes spiked with possum faecal material were kept at room temperature and at the commencement of each week 500 µl of water from each of these tubes was tested by IS2404 and ppk qPCR to estimate the residual quantity in the water of M. ulcerans and M. marinum respectively . Results were reported as cfu by reference to standard curves for each PCR and bacterial species, correlating qPCR Ct values with cfu . From weeks 2–5 the larvae were sustained with small quantities of fish food added to each tube. A larva was taken from each tube as it progressed through each instar and tested by IS2404 PCR for the presence of M. ulcerans as described . A selection of 4th instar larvae were also fixed overnight in 10% formaldehyde in PBS (v/v) then mounted in cedarwood oil (Matheson, Coleman and Bell) on a glass slide for examination by fluorescence microscopy with an Olympus BX51 microscope (Olympus, Tokyo, Japan) with the following filter sets: DAPI (Blue) ex: 360–70 nm, em: 420–60 nm, FITC (Green) ex: 450–80 nm, em: 535 nm, TRITC (red) ex: 535 nm, em: 635 nm. Images were acquired using an Olympus DP-70 digital camera and merged using DP controller software (version 220.127.116.11) or Adobe Photoshop (version 8) These experiments were terminated before the insects progressed to pupal and adult developmental stages.
Identification of promoter regions in mycolactone-associated genes using a GFP-reporter
By cloning DNA fragments ranging from 229 bp–1646 bp located immediately upstream of mlsA1/mlsB (these genes have a duplicated start and upstream sequence so one cloned fragment was sufficient to analyse both genes), mlsA2, mup038, mup045 and mup053 in the promoterless GFP E. coli/Mycobacterium reporter vector pSM20 (Table S1, Figure 1) we were able to discover regions containing promoter activities. The resulting plasmids were used to transform E. coli, M. smegmatis and, for the mlsA1/mlsB construct, M. marinum and M. ulcerans were also transformed. Bacteria were cultured in 96-well plates for 2 hours at 37°C and expression of GFP for each strain was assessed by continuous fluorescence measurements. E. coli expressing GFP from the strong, constitutive promoter srp (pSM22)  and M. smegmatis expressing GFP from the sigA promoter from Mycobacterium bovis BCG (pJKD3042)  were used as positive controls for each genus. Results were expressed as fold changes in fluorescence above the levels detected in bacteria containing the empty vector pSM20. The results for mlsA1 and mlsB are summarized in Figure 2 and show that strains containing the construct pJKD2893 with the region 1646 bp upstream of mlsA1/mlsB, led to detectable GFP expression in E. coli, and high levels of GFP expression in M. smegmatis and M. marinum (Figure 2A). A single copy version of pJKD2893 was also created where a DNA fragment spanning the 1646 bp mls upstream region and gfp gene from pJKD2893 was subcloned into the mycobacterial integrating shuttle vector, pJKD8003 resulting in pJKD3111. M. marinum transformed with pJKD3111 expressed GFP 40-fold less than the same strain containing pJKD2893 (Figure 2A).
Shown are plasmid constructs with upstream regions from M. ulcerans mlsA1/mlsB (A) & (B). Also shown are the sigA promoter from M. bovis BCG (construct pJKD3042) (B) and the srp promoter from E. coli (construct pSM22) (B). Point mutations in putative promoter regions in the putative -10 motifs of promoter regions for mls sequences are marked by ‘X’. All values are expressed as fold changes above the strain containing the empty vector pSM20. Strains are identifiable by a two-letter prefix to the strain number EC - E. coli, MS - M. smegmatis, MM - M. marinum and MU - M. ulcerans. ‘*’ indicates this fluorescence is more than 100-fold higher than vector alone.
To further localize the region conferring promoter activity within the 1646 bp upstream of mlsA1/mlsB, four overlapping sub-clones of this region were prepared by PCR, cloned into pSM20 and used to transform E. coli and M. smegmatis. Comparison of GFP expression in these constructs in another time course experiment, comparing fluorescence with the full-length 1646 bp fragment and controls, clearly showed that promoter activity was restricted to a 413 bp fragment located between nucleotide positions 35996-36409 for mlsA1 and 100821-101234 for mlsB in pMUM001 (Figure 2B).
The region 1440 bp upstream of mup045 and 1466 bp upstream of mup053 also led to significant GFP expression in M. smegmatis, 8–15 fold above background, but these regions showed little transcriptional activity in E. coli (Figure S1). No fluorescence was observed in either E. coli or M. smegmatis for strains containing the 229 bp region upstream of mup038 (pJKD3269) or the 1096 bp region upstream of mlsA2 (pJKD3041) (data not shown). These experiments demonstrate that the regions upstream from mlsA1/mlsB, mup045 and mup053 all harbour at least one strong promoter.
Identification of transcriptional start points (TSPs) for mlsA1/mlsB, mup045, and mup053
To identify TSPs upstream of each gene primer extension (PE) analysis was performed using RNA extracted from M. ulcerans Agy99. For mlsA1/mlsB, RNA was also extracted from M. marinum harbouring the GFP expression construct pJKD2893. One or more 5′ 6-FAM-labeled antisense oligonucleotides were used to prime cDNA synthesis to determine the TSP for mlsA1/mlsB, mup045, and mup053 (Table S2). Single, distinct PE products were identified for all three regions using multiple RNA preparations (Figure S2, Figure S3). Size fragment analysis of the PE products suggested single TSPs at 533 bp (T533) upstream of the mlsA1/mlsB translational start (Figure S2), 207 bp upstream of mup045 (T207), and 68 bp upstream of mup053 (T068) (Figure S3). Primer extension analysis of mup038 and mlsA2 was not attempted due to the lack of promoter activity observed with the wild type sequences in the GFP reporter assays.
Localization of putative promoter sequences by in silico analysis
Several studies of promoters in mycobacteria facilitated the construction of position-specific scoring matrices (PSSMs) to perform in silico searches for potential regulatory regions in DNA sequences . We used sigma factor-specific libraries of PSSMs to scan the regions upstream of the three TSPs identified by our PE analysis. High-probability SigA-like promoter motifs were predicted in the regions upstream of mlsA1/mlsB and mup045 and a SigD-like motif was predicted upstream of mup053 (Table 1).
Confirmation of putative promoter elements by site-directed mutagenesis
To confirm the in silico promoter predictions, the GFP expression constructs spanning the putative -10 sequences from mlsA1/mlsB (pJKD2893), mup045 (pJKD3040) and mup053 (pJKD3039) were mutated by PCR (Table 1). GFP production by E. coli and M. smegmatis harbouring these constructs was assayed as before by continuous fluorescence measurements over 2 hours at 37°C. Fluorescence production was compared with the same strains containing the wild-type putative promoter sequences. Mutation of the proposed −10 boxes for both the mlsA1/mlsB and mup045 reduced fluorescence in M. smegmatis to less than 4% of the wild-type sequences, strongly suggesting these sequences are functional −10 motifs, required for proper binding of the sigma factor and RNA polymerase to initiate transcription (Figure 2B). Mutation of the proposed −10 box from mup053 had no impact on GFP expression.
Construction and analysis of M. ulcerans expressing GFP under the control of the mlsA1/mlsB promoter
The strength of the mls promoter led us to develop a GFP-producing strain of M. ulcerans that might be useful in studies of pathogenesis or transmission. We transformed M. ulcerans JKD8049 with plasmid pJKD2893, resulting in highly green fluorescent M. ulcerans (JKD8083 or M. ulcerans-GFP), with fluorescence expression more than 100 fold above empty vector (Figure 2A). To ensure that GFP expression did not stop mycolactone production we performed cell LC-MS analysis of acetone-soluble lipids from cultures of JKD8083 and confirmed the presence of mycolactone A/B and C (Figure S4).
M. ulcerans-GFP retains virulence in vivo
Mouse-tail infection is a well-established animal model for studying M. ulcerans. Forty days after subcutaneous inoculation of 105 M. ulcerans-GFP oedema was observed and on the 50th day the lesion became ulcerated and the mice were killed. Histological study of the ulcerated region showed an area of necrosis consistent with wild type M. ulcerans infection (Figure 3A, Figure 3B). Granulomatous inflammation was not observed. Acid-fast bacilli were localized in clumps in necrotic areas (Figure 3C) and expressed green fluorescent protein (Figure 3D). The viability of these bacteria was demonstrated by re-isolating them in bacterial culture media. These results demonstrate that M. ulcerans-GFP is virulent in the mouse model and provokes lesions typical of M. ulcerans infection.
(A) Fifty days after subcutaneous inoculation in the tail of 105 bacilli showing the beginning of ulceration. (B) Hematoxylin phloxine saffron staining on tissue section reveals massive necrosis. (C) Ziehl-Nieelsen staining showing many extracellular individual and clustered bacilli (arrowheads) associated with necrosis, and (D) bacilli expressing GFP. Scale bars: 0.8 cm (A), 100 µm (B, C, and D) and 40 µm (C and D insets).
M. ulcerans-GFP accumulates within mosquito larvae
Adult mosquitoes in some Buruli ulcer endemic regions of Australia have tested PCR positive for M. ulcerans and epidemiological evidence suggests a role for biting insects in the disease ecology of M. ulcerans ,. These data and the presence of M. ulcerans in possum faecal material from the same endemic regions has led to the hypothesis that larval stages of mosquitoes may and probably do ingest M. ulcerans as well as other bacteria via filter feeding activity on decomposing, faecally contaminated environments . We mimicked this environment by establishing simple aquatic microcosms, seeded with 1 or 2 instar Aedes camptorhynchus larvae that were then transiently fed with possum faecal material, spiked with either M. ulcerans-GFP or M. marinum-GFP (Figure 4A). M. ulcerans and M. marinum were initially liberated into the water from the food source but neither bacterial species were detectable in water by week 4 (Figure 4B). Analysis of 4th instar larvae at week 4 by fluorescence microscopy revealed an accumulation of M. ulcerans primarily within the larval midgut and around the mouthpart (Figure 4C). Fourth instar larvae assayed by PCR for M. ulcerans had a mean bacterial load of 27,300±15,200 cfu (n = 4). The same pattern of accumulation within the insect was not seen with M. marinum-GFP with very few fluorescent bacteria observed in association with larvae (Figure 4C). Neither M. ulcerans or M. marinum were detected in the microcosms containing mosquito larvae only (Figure 4C). These data show that mosquito larvae in contaminated aquatic environments were able to ingest and maintain M. ulcerans within regions of the digestive tract over a significant time period.
(A) Epifluorescence microscopy (x100 objective) demonstrating that the majority of total fluorescent bacteria (DAPI-staining, blue filter) are also GFP-expressing M. ulcerans (JKD8083) and M. marinum (JKD8062) (green filter). (B) Reduction of M. marinum and M. ulcerans within the water of the microcosms over the 4-week duration of the experiment as measured by qPCR. Results are the means and standard deviations of four biological repeats. (C) Bright field, red fluorescence, green fluorescence and composite images showing the accumulation of M. ulcerans around the mouth and mid-gut of a 4th instar Aedes camptorhynchus larva. Scale bar indicates 0.5 mm. Inset images are ×400 magnification. No specific green fluorescence was observed in larvae infected with M. marinum or uninfected controls. Red fluorescence images were included to show that green fluorescence was due to GFP expression and not autofluorescence.
In this study we have explored gene expression of six pMUM001 genes required or implicated in mycolactone synthesis and attempted to identify their transcriptional start sites and promoter motifs.
Using a combination of primer extension and in silico analysis together with a GFP reporter system, we were able to identify a SigA-like promoter that drives expression of the mycolactone polyketide megasynthases mlsA and mlsB in M. ulcerans. Primer extension analyses with mRNA extracted from E. coli, M. smegmatis and M. marinum bearing the GFP reporter construct pJKD2893 and from wild-type M. ulcerans Agy99 all consistently demonstrated a transcription start point (TSP) 533 bp upstream of the mlsA1/mlsB initiation codons. The primer extension analysis was fully supported by the GFP expression data, wherein only strains containing expression constructs that spanned the TSP at T533 produced fluorescence. These results indicate the presence of a strong promoter preceding position T533. Sequence scanning using PoSSuM of the region immediately upstream of T533 for mycobacterial consensus promoter sequences predicted a high probability SigA-like promoter (Table 1). Site-directed mutagenesis of the putative −10 box by substitution of three nucleotides completely abolished GFP expression (Table 1, Figure 2B), implicating this sequence in RNA polymerase (RNAP) binding. The mlsA/mlsB promoter lies between two pseudogenes that once encoded transposases. These CDS appear to be remnants of two distinct insertion sequence elements (ISE) as the partial transposase sequences display similarity to two different IS families (IS3 family for MUP034/MUP042 and the IS6 family for MUP033/MUP041) . These vestigial ISE are quite distinct to the two high copy number elements, IS2404 and IS2606 present in M. ulcerans. It is possible that the T533 promoter was once a component of an ISE. A role for ISE in altering gene expression in mycobacteria has been reported . Similarly, we investigated DNA sequences upstream of mup045 and found a TSP at T207 with a potential SigA promoter element predicted by PoSSuM and confirmed by a loss of GFP expression in M. smegmatis following mutagenesis of the proposed −10 box. The principal mycobacterial sigma factor sigA is utilized by genes expressed during exponential growth , thus the data from mlsA/B and mup045 fit well with our previous report that show these genes are constantly expressed during exponential growth in the heterologous host, M. marinum .
PoSSuM sequence scanning predicted a SigA-like promoter upstream of mup045, a finding confirmed by mutagenesis of its putative −10 motif (Table 1). The same in silico search suggested a SigD-like promoter element upstream of mup053. However, mutation of the putative −10 motif for this gene resulted in no significant difference in GFP production in either E. coli and M. smegmatis backgrounds compared to wild type sequence, indicating that this was not the promoter region or that the introduced mutations were not sufficiently different to the wild type sequence to alter transcription. The latter scenario seems more likely given the low complexity of SigD −10 consensus sequences (Table 1).
The discovery in this study of the strong SigA-like promoter, active in diverse bacterial genera, and driving expression of the mycolactone mls PKS genes prompted us to transform M. ulcerans with a reporter plasmid with GFP under the control of the T533 mls promoter, resulting in the highly green fluorescent strain M. ulcerans JKD8049. M. ulcerans-GFP still produced mycolactone and was capable of causing disease in a mouse-tail infection model. Interestingly, GFP expression was more than 2-fold higher in M. ulcerans than in M. marinum harbouring the same plasmid (Figure 2A), suggesting additional regulatory factors might augment mls expression in M. ulcerans (or conversely, repress gene expression from the same promoter in other mycobacteria). The high level of mls promoter activity and the presence of viable M. ulcerans-GFP in the ulcerated tail tissue 50 days post inoculation implies that there was sustained expression of the mycolactone PKS and presumably sustained mycolactone production by the bacteria within necrotic tissue (Figure 3). These observations demonstrate the utility of this M. ulcerans-GFP strain as a tool for following the dynamics of mls gene expression during infection and understanding the role of mycolactone in pathogenesis.
We also used M. ulcerans-GFP to explore the previously reported association of M. ulcerans with Aedes camptorhynhcus mosquitoes . Here, we addressed the specific question of whether or not A. camptorhynchus larvae could ingest M. ulcerans via feeding on possum faecal material and whether the bacteria could persist through the larval growth stages. Many larval mosquito species filter feed on microbial particles and detritus where they aggregate at air-water interfaces near plant stems and algal mats in lentic waters , and a recent report has also suggested that M. ulcerans can persist within the gut of Ochlerotatus triseriatus mosquito larvae . We were also able to observe the presence of M. ulcerans within the gut contents of mosquito larvae in laboratory experiments. However, the mode of larval ingestion via possum faecal pellets that we have employed in this study, presents a natural and viable pathway that A. camptorhynchus larvae as well as other filter-feeding macroinvertebrates might become infected for a long period of time with M. ulcerans. The peritrophic matrix is a proteoglycan ‘sleeve’ that separates food sources from the gut epithelium in insects  and our data suggests an accumulation of M. ulcerans within this matrix through each instar (Figure 4C). The significantly greater mean bacterial load of M. ulcerans-GFP found in fourth instar larvae compared to M. marinum-GFP may indicate that A. camptorhynchus larvae are able to digest and assimilate M. marinum-GFP better than M. ulcerans or that M. ulcerans is able to persist and perhaps multiply within the peritrophic matrix. Production of GFP in the mosquito larvae also indicates that the mycolactone mls genes are likely to be expressed and producing mycolactone under these conditions. Whether or not M. ulcerans can be transferred through larval, pupal and then adult insects remains to be tested. Experiments are now underway to examine vertical transmission of M. ulcerans within mosquitoes.
The data presented in this study provide the first insights into gene expression within the mycolactone biosynthesis locus and the development of M. ulcerans-GFP, a strain where fluorescence and toxin gene expression are linked thus providing a tool for studying Buruli ulcer pathogenesis and potential transmission to humans.
Bacterial strains and plasmids used in this study.
(0.09 MB DOC)
Oligonucleotides used in this study.
(0.07 MB DOC)
Summary of fluorescence data demonstrating the difference in promoter activity among strains containing GFP reporter plasmid constructs. Shown are upstream regions from M. ulcerans mup045 (A) and mup053 (B). Point mutations in putative promoter region in the putative -10 motif of the mup045 promoter region is marked by ‘X’. All values are expressed as fold changes above the strain containing the empty vector pSM20. Strains are identifiable by a two-letter prefix to the strain number EC - E. coli, MS - M. smegmatis, MM - M. marinum and MU - M. ulcerans.
(0.19 MB DOC)
Overview of the mls upstream region and primer extension analysis. (A) Annotation of the sequence upstream of mlsA1/mlsB showing the start position of the mls genes and the putative mls TSP (indicated by “*”) with predicted -10 and -35 promoter motifs assigned for each TSP (boxed). Representative results are shown for fluorescent PE analysis performed on RNA from (B) M. marinum 8062 and (C) M. ulcerans for mls using primer PE-1. Primers PE-2 and PE-LM were used to cover the entire mls upstream region (refer arrows in figure for primer binding positions). PE analysis curves indicate the size (sz), height (ht) and area under the curve (ar) of peaks consistently detected by DNA fragment analysis.
(0.15 MB DOC)
Overview of the mup045 and mup053 upstream regions and primer extension analysis. (A) Annotation of the sequence upstream of mup045 indicating the putative TSP identified (indicated by “*”) as well as putative -10 and -35 promoter sequences assigned by PoSSuM (boxed). The fluorescently labelled primer is also indicated (arrow) (B) PE analysis graphs indicate the size (sz), height (ht) and area under the curve (ar) of peaks consistently detected by DNA fragment analysis. (C) Annotation of the sequence upstream of mup053 indicating the putative TSP identified (indicated by “*”) as well as putative -10 and -35 promoter sequences assigned by PoSSuM (boxed). The fluorescently labelled primer is also indicated (arrow) (D) PE analysis graphs indicate the size (sz), height (ht) and area under the curve (ar) of peaks consistently detected by DNA fragment analysis.
(0.15 MB DOC)
Liquid chromatography-mass spectrometry analysis of acetone soluble lipid extracts from M. ulcerans-GFP. Indicated is the presence of mycolactone A/B ([M+Na]+ at m/z 765.5) and the presence of the nonhydroxylated mycolactone ([M+Na]+ at m/z 749.5). (A) Ion trace for m/z 765.5; (B) ion trace for m/z 749.5.
(0.10 MB DOC)
We thank J. Fyfe and L. Ramakrishnan for the provision of M. ulcerans and M. marinum strains respectively. We are grateful to Delan Adikari and Irene Hatzinisiriou for expert technical assistance and P. Small for helpful discussions.
Conceived and designed the experiments: NJT LM JA JRW JKD PDRJ GAJ TPS. Performed the experiments: NJT TS JLP LM EM FL TZ HH GAJ TPS. Analyzed the data: NJT TS SJP LM EM TZ JA JRW HH JKD BPH PDRJ GAJ TPS. Contributed reagents/materials/analysis tools: NJT TS SJP JLP LM EM FL TZ JA HH BPH PDRJ GAJ. Wrote the paper: NJT JRW TPS.
- 1. Amofah G, Bonsu F, Tetteh C, Okrah J, Asamoa K, et al. (2002) Buruli ulcer in Ghana: results of a national case search. Emerg Infect Dis 8: 167–170.
- 2. Debacker M, Aguiar J, Steunou C, Zinsou C, Meyers WM, et al. (2004) Mycobacterium ulcerans disease (Buruli ulcer) in rural hospital, Southern Benin, 1997–2001. Emerg Infect Dis 10: 1391–1398.
- 3. Chauty A, Ardant MF, Adeye A, Euverte H, Guédénon A, et al. (2007) Promising clinical efficacy of streptomycin-rifampin combination for treatment of Buruli ulcer (Mycobacterium ulcerans disease). Antimicrob Agents Chemother 51: 4029–4035.
- 4. van der Werf TS, van der Graaf WT, Tappero JW, Asiedu K (1999) Mycobacterium ulcerans infection. Lancet 354: 1013–1018.
- 5. Eddyani M, Ofori-Adjei D, Teugels G, De Weirdt D, Boakye D, et al. (2004) Potential role for fish in transmission of Mycobacterium ulcerans disease (Buruli ulcer): an environmental study. Appl Environ Microbiol 70: 5679–5681.
- 6. Marsollier L, Severin T, Aubry J, Merritt RW, Saint Andre JP, et al. (2004) Aquatic snails, passive hosts of Mycobacterium ulcerans. Appl Environ Microbiol 70: 6296–6298.
- 7. Portaels F, Elsen P, Guimaraes-Peres A, Fonteyne PA, Meyers WM (1999) Insects in the transmission of Mycobacterium ulcerans infection. Lancet 353: 986.
- 8. Marsollier L, Brodin P, Jackson M, Kordulakova J, Tafelmeyer P, et al. (2007) Impact of Mycobacterium ulcerans biofilm on transmissibility to ecological niches and Buruli ulcer pathogenesis. PLoS Pathog 3: e62.
- 9. Johnson PD, Hayman JA, Quek TY, Fyfe JA, Jenkin GA, et al. (2007) Consensus recommendations for the diagnosis, treatment and control of Mycobacterium ulcerans infection (Bairnsdale or Buruli ulcer) in Victoria, Australia. Med J Aust 186: 64–68.
- 10. Quek TY, Henry MJ, Pasco JA, O'Brien DP, Johnson PD, et al. (2007) Mycobacterium ulcerans infection: factors influencing diagnostic delay. Med J Aust 187: 561–563.
- 11. George KM, Chatterjee D, Gunawardana G, Welty D, Hayman J, et al. (1999) Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence. Science 283: 854–857.
- 12. Gunawardana G, Chatterjee D, George KM, Brennan P, Whittern D, et al. (1999) Characterization of novel macrolide toxins, mycolactones A and B, from a human pathogen, Mycobacterium ulcerans. J Am Chem Soc 121: 6092–6093.
- 13. Brown EJ, Albers MW, Shin TB, Ichikawa K, Keith CT, et al. (1994) A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature 369: 756–758.
- 14. Burg RW, Miller BM, Baker EE, Birnbaum J, Currie SA, et al. (1979) Avermectins, new family of potent anthelmintic agents: producing organism and fermentation. Antimicrob Agents Chemother 15: 361–367.
- 15. McGuire JM, Bunch RL, Anderson RC, Boaz HE, Flynn EH, et al. (1952) Ilotycin, a new antibiotic. Schweiz Med Wochenschr 82: 1064–1065.
- 16. Coutanceau E, Marsollier L, Brosch R, Perret E, Goossens P, et al. (2005) Modulation of the host immune response by a transient intracellular stage of Mycobacterium ulcerans: the contribution of endogenous mycolactone toxin. Cell Microbiol 7: 1187–1196.
- 17. Pahlevan AA, Wright DJ, Andrews C, George KM, Small PL, et al. (1999) The inhibitory action of Mycobacterium ulcerans soluble factor on monocyte/T cell cytokine production and NF-kappa B function. J Immunol 163: 3928–3935.
- 18. Torrado E, Adusumilli S, Fraga AG, Small PL, Castro AG, et al. (2007) Mycolactone-mediated inhibition of tumor necrosis factor production by macrophages infected with Mycobacterium ulcerans has implications for the control of infection. Infect Immun 75: 3979–3988.
- 19. Hong H, Coutanceau E, Leclerc M, Caleechurn L, Leadlay PF, et al. (2008) Mycolactone diffuses from Mycobacterium ulcerans-infected tissues and targets mononuclear cells in peripheral blood and lymphoid organs. PLoS Negl Trop Dis 2: e325.
- 20. Mve-Obiang A, Lee RE, Umstot ES, Trott KA, Grammer TC, et al. (2005) A newly discovered mycobacterial pathogen isolated from laboratory colonies of Xenopus species with lethal infections produces a novel form of mycolactone, the Mycobacterium ulcerans macrolide toxin. Infect Immun 73: 3307–3312.
- 21. Ranger BS, Mahrous EA, Mosi L, Adusumilli S, Lee RE, et al. (2006) Globally distributed mycobacterial fish pathogens produce a novel plasmid-encoded toxic macrolide, mycolactone F. Infect Immun 74: 6037–6045.
- 22. Stinear TP, Mve-Obiang A, Small PL, Frigui W, Pryor MJ, et al. (2004) Giant plasmid-encoded polyketide synthases produce the macrolide toxin of Mycobacterium ulcerans. Proc Natl Acad Sci U S A 101: 1345–1349.
- 23. Yip MJ, Porter JL, Fyfe JA, Lavender CJ, Portaels F, et al. (2007) Evolution of Mycobacterium ulcerans and other mycolactone-producing mycobacteria from a common Mycobacterium marinum progenitor. J Bacteriol 189: 2021–2029.
- 24. Hong H, Stinear T, Porter J, Demangel C, Leadlay PF (2007) A novel mycolactone toxin obtained by biosynthetic engineering. Chembiochem 8: 2043–2047.
- 25. Stinear TP, Pryor MJ, Porter JL, Cole ST (2005) Functional analysis and annotation of the virulence plasmid pMUM001 from Mycobacterium ulcerans. Microbiology 151: 683–692.
- 26. Stinear TP, Seemann T, Pidot S, Frigui W, Reysset G, et al. (2007) Reductive evolution and niche adaptation inferred from the genome of Mycobacterium ulcerans, the causative agent of Buruli ulcer. Genome Res 17: 192–200.
- 27. Kaser M, Rondini S, Naegeli M, Stinear T, Portaels F, et al. (2007) Evolution of two distinct phylogenetic lineages of the emerging human pathogen Mycobacterium ulcerans. BMC Evol Biol 7: 177.
- 28. Kaser M, Hauser J, Small P, Pluschke G (2009) Large sequence polymorphisms unveil phylogenetic relationship of environmental and pathogenic mycobacteria related to Mycobacterium ulcerans. Appl Environ Microbiol.
- 29. Stinear TP, Hong H, Frigui W, Pryor MJ, Brosch R, et al. (2005) Common evolutionary origin for the unstable virulence plasmid pMUM found in geographically diverse strains of Mycobacterium ulcerans. J Bacteriol 187: 1668–1676.
- 30. Hong H, Spencer JB, Porter JL, Leadlay PF, Stinear T (2005) A novel mycolactone from a clinical isolate of Mycobacterium ulcerans provides evidence for additional toxin heterogeneity as a result of specific changes in the modular polyketide synthase. Chembiochem 6: 643–648.
- 31. Pidot SJ, Hong H, Seemann T, Porter JL, Yip MJ, et al. (2008) Deciphering the genetic basis for polyketide variation among mycobacteria producing mycolactones. BMC Genomics 9: 462.
- 32. McKean S, Davies J, Moore R (2005) Identification of macrophage induced genes of Corynebacterium pseudotuberculosis by differential fluorescence induction. Microbes Infect 7: 1352–1363.
- 33. Snapper SB, Melton RE, Mustafa S, Kieser T, Jacobs WR Jr (1990) Isolation and characterization of efficient plasmid transformation mutants of Mycobacterium smegmatis. Mol Microbiol 4: 1911–1919.
- 34. Talaat AM, Trucksis M (2000) Transformation and transposition of the genome of Mycobacterium marinum. Am J Vet Res 61: 125–128.
- 35. Porter JL, Tobias NJ, Hong H, Tuck KL, Jenkin GA, et al. (2009) Transfer, stable maintenance and expression of the mycolactone polyketide megasynthase mls genes in a recombination-impaired Mycobacterium marinum. Microbiology 155: 1923–1933.
- 36. Dussault AA, Pouliot M (2006) Rapid and simple comparison of messenger RNA levels using real-time PCR. Biol Proced Online 8: 1–10.
- 37. Lloyd AL, Marshall BJ, Mee BJ (2005) Identifying cloned Helicobacter pylori promoters by primer extension using a FAM-labelled primer and GeneScan analysis. J Microbiol Methods 60: 291–298.
- 38. Unniraman S, Chatterji M, Nagaraja V (2002) DNA gyrase genes in Mycobacterium tuberculosis: a single operon driven by multiple promoters. J Bacteriol 184: 5449–5456.
- 39. Beckstette M, Homann R, Giegerich R, Kurtz S (2006) Fast index based algorithms and software for matching position specific scoring matrices. BMC Bioinformatics 7: 389.
- 40. Rodrigue S, Provvedi R, Jacques PE, Gaudreau L, Manganelli R (2006) The sigma factors of Mycobacterium tuberculosis. FEMS Microbiol Rev 30: 926–941.
- 41. Ho SN, Hunt HD, Horton RM, Pullen JK, Pease LR (1989) Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77: 51–59.
- 42. Kubica GP, Dye WE, Cohn ML, Middlebrook G (1963) Sputum digestion and decontamination with N-acetyl-L-cysteine-sodium hydroxide for culture of mycobacteria. Am Rev Respir Dis 87: 775–779.
- 43. Fyfe JA, Lavender CJ, Johnson PD, Globan M, Sievers A, et al. (2007) Development and application of two multiplex real-time PCR assays for the detection of Mycobacterium ulcerans in clinical and environmental samples. Appl Environ Microbiol 73: 4733–4740.
- 44. Das Gupta SK, Bashyam MD, Tyagi AK (1993) Cloning and assessment of mycobacterial promoters by using a plasmid shuttle vector. J Bacteriol 175: 5186–5192.
- 45. Johnson PD, Azuolas J, Lavender CJ, Wishart E, Stinear TP, et al. (2007) Mycobacterium ulcerans in mosquitoes captured during outbreak of Buruli ulcer, southeastern Australia. Emerg Infect Dis 13: 1653–1660.
- 46. Quek TY, Athan E, Henry MJ, Pasco JA, Redden-Hoare J, et al. (2007) Risk factors for Mycobacterium ulcerans infection, southeastern Australia. Emerg Infect Dis 13: 1661–1666.
- 47. Fyfe JA, O'Brien C, Lavender CJ, Johnson PDR (2009) A role for small mammals in the ecology of Mycobacterium ulcerans. World Health Organisation Annual Meeting on Buruli ulcer. Cotonou, Benin.
- 48. Doran T, Tizard M, Millar D, Ford J, Sumar N, et al. (1997) IS900 targets translation initiation signals in Mycobacterium avium subsp. paratuberculosis to facilitate expression of its hed gene. Microbiology 143 (Pt2): 547–552.
- 49. Hu Y, Coates AR (1999) Transcription of two sigma 70 homologue genes, sigA and sigB, in stationary-phase Mycobacterium tuberculosis. J Bacteriol 181: 469–476.
- 50. Merritt RW, Dadd RH, Walker ED (1992) Feeding behavior, natural food, and nutritional relationships of larval mosquitoes. Annual Review of Entomology.
- 51. Wallace JR, Merritt RW (1999) Influence of microclimate, food, and predation on Anopheles quadrimaculatus. Environmental entomology.
- 52. Mosi L, Williamson H, Wallace JR, Merritt RW, Small PL (2008) Persistent association of Mycobacterium ulcerans with West African predaceous insects of the family belostomatidae. Appl Environ Microbiol 74: 7036–7042.
- 53. Lehane MJ (1997) Peritrophic matrix structure and function. Ann Rev Entomol 54: 285–302.